Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MicroTech Medical (Hangzhou) Co., Ltd. Class H ( (HK:2235) ) has issued an announcement.
MicroTech Medical (Hangzhou) Co., Ltd. held its first extraordinary general meeting of 2025 in Hangzhou, where all resolutions put to shareholders were approved by poll. With 71.29% of voting shares represented, shareholders backed both the adoption of a new share incentive scheme and the mandate for the board and/or its administrative committee to manage matters related to the scheme, after excluding treasury shares and those held under the H Share Award and Trust Scheme that were required to abstain. The approval strengthens the company’s ability to implement equity-based incentives, which may support its efforts to attract and retain talent and better align management and shareholder interests.
The most recent analyst rating on (HK:2235) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on MicroTech Medical (Hangzhou) Co., Ltd. Class H stock, see the HK:2235 Stock Forecast page.
More about MicroTech Medical (Hangzhou) Co., Ltd. Class H
MicroTech Medical (Hangzhou) Co., Ltd. is a medical technology company based in Hangzhou, China, whose H shares are listed on the Hong Kong Stock Exchange. The company operates under PRC company law with a mix of unlisted and H shares, and uses equity-based incentive schemes as part of its capital and talent management strategy.
Average Trading Volume: 247,968
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.25B
See more insights into 2235 stock on TipRanks’ Stock Analysis page.